AstraZeneca PLC is 14.9x more valuable than Viatris Inc by market capitalization ($286.27 B vs $19.19 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VTRS | AZN |
|---|---|---|
| Market cap | $19.19 B | $286.27 B |
| US-listed rank | #651 | #49 |
| Revenue (latest FY) | $14.30B | - |
| Net income (latest FY) | $0.00 | - |
| Net margin | 0.0% | - |
| SEC filings | 519 | 1,004 |
AstraZeneca PLC is 14.9x more valuable than Viatris Inc by market capitalization ($286.27 B vs $19.19 B).
Full pages: Viatris Inc and AstraZeneca PLC, or browse the full rankings.